National Institutes of Health logo
NIH Research Project Grant

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System

Funds basic research on how nerve agents, industrial chemicals and pesticides injure the nervous system, and where a countermeasure could interrupt it.

Between cyclesNational Institutes of HealthUnited States

This is the National Institutes of Health arm of the government's chemical countermeasures work, and it pays for the science underneath a treatment rather than the treatment itself.

Three kinds of compound are in scope: chemical warfare agents, toxic industrial chemicals, and pesticides. What links them here is the target โ€” each has primary or secondary effects on the nervous system. The scenarioโ€ฆ

Basic research on the neurotoxic mechanisms of chemical warfare agents, toxic industrial chemicals and pesticides, including unrecognised manifestations of exposure and the identification of therapeutic targets for medical countermeasures. Clinical trials are not allowed.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.$300K

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
National Institutes of Health logo
Open

GREGoRi Data Coordination and Outreach Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.

BiotechAI
$1.3MOct'26
National Institutes of Health logo
Open

GREGoRi Innovation Projects

NIH ยท United States

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

BiotechAI
$3 โ€“ $500KOct'26
National Institutes of Health logo
Open

GREGoRi Technology Integration Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.

BiotechAI
$2.3MOct'26
National Institutes of Health logo
Open

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.

Medtech
Nov'26
National Institutes of Health logo
Open

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.

MedtechBiotech
Nov'26
National Institutes of Health logo
Open

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)

NIH ยท United States

Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.

BiotechAI
Nov'26